<DOC>
	<DOCNO>NCT01453114</DOCNO>
	<brief_summary>The overarch goal study adapt cognitive behavioral prevention recurrence treatment ( CBT-PR ) woman history recurrent major depressive disorder decide discontinue maintenance anti-depressant ( AD ) treatment pregnancy .</brief_summary>
	<brief_title>Cognitive-Behavioral Therapy ( CBT ) Women Discontinuing Antidepressant Pregnancy</brief_title>
	<detailed_description>The current study small year-long pilot collect data plan large , randomize control trial future . The current protocol focus modify Cognitive-Behavioral Therapy ( CBT ) recurrence prevention protocol study population , finalize therapist train manual , finalize therapist adherence competence scale , fine tune research procedure recruitment retention subject . This phase involve enrol 20 subject order least 12 subject receive CBT treatment 12 week assessments conduct bimonthly . The subject option additional monthly `` booster '' CBT session . Independent Assessments HRC-approved study staff interview study psychiatrists occur 16 week , 24 week , 36 week , 1 year study initiation . Participants offer opportunity speak study psychiatrist every visit . The primary outcome measure rate recurrence and/or re-initiation antidepressant treatment 12 month post-randomization . The study end point procedure 12 week baseline ; study end point follow-up assessment one year treatment . At point enrollment , subject review risk benefit perinatal depression treatment consultation non-study psychiatrist MGH Center Women 's Mental Health ( CWMH ) program collaboration subject 's primary psychiatrist , decide discontinue AD treatment . The potential subject undergo preliminary phone screen CWMH research coordinator basic eligibility criterion review . If potential subject interested , schedule baseline study visit conduct PIs another study clinician . After explanation study procedure , write , informed consent obtain . This occur prior execution study assessment procedure . After consent obtain , clinician conduct structure clinical interview use MINI HRC-approved study staff complete study assessment . If potential subject continue interested participate study remain eligible , meet study psychiatrist instruct begin taper antidepressant , already start taper . The subject meet clinician administer CBT treatment first session After 12 week pass , subject ask complete assessment 16 week , 24 week , 36 week , 1 year beginning study , able choose continue monthly booster session CBT-PR . Subjects also offer opportunity meet study psychiatrist every booster session . Visits study psychiatrist arrange discretion study psychologist and/or upon participant request . An optional qualitative interview conduct study staff completion acute treatment phase order obtain feedback intervention . Participants experience relapse depressive symptom study participation option remain study continue receive CBT treatment regardless decision regard antidepressant treatment . Additionally , investigator ask patient experience relapse complete questionnaire regard course relapse treatment decision one year study enrollment . This questionnaire complete phone home return mail .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Subjects include woman 18 year old either plan pregnancy already pregnant meet follow criterion : Currently meet criterion stable remission depression ( defined baseline score â‰¤ 9 Hamilton Rating Scale Depression ( HRSD ) document clinical remission minimum six month prior randomization ) Current recent treatment antidepressant ( stable dosage least last four week ) Have history major depressive episode Decide discontinue antidepressant medication pregnancy Currently receive ongoing psychiatric care provide physician outside MGH Center Women 's Mental Health , write , informed consent . Significant risk selfharm harm others Psychotic symptom Meeting criterion primary SCIDI/P diagnosis schizophrenia , bipolar disorder , active eating disorder , dementia , delirium , cognitive disorder Presence active substance and/or alcohol abuse disorder within six month prior screen visit Current use mood stabilizer , antipsychotic antiepileptic Have receive cognitivebehavioral interpersonal therapy within last year Diagnosed medical disorder know association depressive symptom ( e. g. thyroid disorder ) .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Cognitive Behavioral Therapy</keyword>
	<keyword>CBT</keyword>
	<keyword>relapse</keyword>
	<keyword>postpartum depression</keyword>
	<keyword>depression recurrence</keyword>
	<keyword>depression relapse</keyword>
</DOC>